Literature DB >> 1790624

Bone-alkaline phosphatase as indicator of bone formation.

J P van Straalen1, E Sanders, M F Prummel, G T Sanders.   

Abstract

Bone-alkaline phosphatase was determined in patients at risk of osteoporosis due to treatment with oral corticosteroids, and in patients at risk of increased bone synthesis because of treatment with cyclosporin. Both a significant decrease of bone-alkaline phosphatase during corticosteroid treatment, and a significant increase of bone-alkaline phosphatase during cyclosporin treatment could be demonstrated. It is concluded that bone-alkaline phosphatase is a useful parameter for monitoring changes in bone formation.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1790624     DOI： 10.1016/0009-8981(91)90021-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


  34 in total

Review 1.  Bone metabolism markers in sports medicine.

Authors:  Giuseppe Banfi; Giovanni Lombardi; Alessandra Colombini; Giuseppe Lippi
Journal:  Sports Med       Date:  2010-08-01       Impact factor: 11.136

2.  Individual and combined effects of calciotropic hormones and growth factors on mineral metabolism in embryonic chick tibiae.

Authors:  C Duvos; A Scutt; H Mayer
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-06       Impact factor: 2.416

3.  Effects of resistance training on biomarkers of bone formation and association with red blood cell variables.

Authors:  Min Hu; Taija Finni; Leiting Xu; Liangchou Zou; Sulin Cheng
Journal:  J Physiol Biochem       Date:  2011-03-11       Impact factor: 4.158

4.  The increase in spinal bone density that occurs in response to fluoride therapy for osteoporosis is not maintained after the therapy is discontinued.

Authors:  J R Talbot; M M Fischer; S M Farley; C Libanati; J Farley; A Tabuenca; D J Baylink
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

5.  Association between metabolic syndrome and bone loss at various skeletal sites in postmenopausal women: a 3-year retrospective longitudinal study.

Authors:  B-J Kim; S H Ahn; S J Bae; E H Kim; T-H Kim; S H Lee; H-K Kim; J W Choe; S-Y Kim; J-M Koh; G S Kim
Journal:  Osteoporos Int       Date:  2013-02-07       Impact factor: 4.507

6.  Bone status and fractures in 85 adults with Wilson's disease.

Authors:  A-S Quemeneur; J-M Trocello; H-K Ea; A Ostertag; A Leyendecker; J-C Duclos-Vallée; M-C de Vernejoul; F Woimant; F Lioté
Journal:  Osteoporos Int       Date:  2014-07-16       Impact factor: 4.507

7.  Age-related changes in bone biochemical markers and their relationship with bone mineral density in normal Chinese women.

Authors:  Yin-Zhen Pi; Xian-Ping Wu; Shi-Ping Liu; Xiang-Hang Luo; Xing-Zhi Cao; Hui Xie; Er-Yuan Liao
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

8.  Biochemical markers of bone turnover: part I: biochemistry and variability.

Authors:  Markus J Seibel
Journal:  Clin Biochem Rev       Date:  2005-11

9.  The association between higher serum ferritin level and lower bone mineral density is prominent in women ≥45 years of age (KNHANES 2008-2010).

Authors:  B-J Kim; S H Lee; J-M Koh; G S Kim
Journal:  Osteoporos Int       Date:  2013-04-17       Impact factor: 4.507

10.  Secondary osteosarcoma arising after treatment for childhood hematologic malignancies.

Authors:  Atsushi Okada; Masahito Hatori; Masami Hosaka; Munenori Watanuki; Eiji Itoi
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.